Affiliate disclosure: Care Path Compare maintains affiliate relationships with telehealth providers including Wellmedr and Gala Health. If you choose to enroll through our links, we may receive compensation at zero extra cost to you. Clinical dosing guidance and titration schedules are based on official FDA clinical protocols and compounding pharmacy best practices.

Milligrams vs. units: understanding compounding vial math

Unlike commercial brand-name autoinjector pens (such as Wegovy or Ozempic) that deliver pre-measured, fixed-volume doses with a push of a button, compounded semaglutide is typically shipped in a multi-dose glass vial alongside separate U-100 insulin syringes.

To measure your dose accurately, you must convert the doctor’s prescribed dose in milligrams (mg) to the liquid volume marked in units on your syringe:

Syringe Units = (Prescribed Dose in mg / Vial Concentration in mg/mL) × 100

A standard U-100 insulin syringe contains 100 unit markings per 1.0 milliliter (mL) of liquid. Therefore:

  • 10 units = 0.10 mL
  • 20 units = 0.20 mL
  • 30 units = 0.30 mL
  • 50 units = 0.50 mL

Because 503A compounding pharmacies dispense semaglutide in different concentrations to keep injection volumes comfortable, confusing your vial concentration can lead to taking half your prescribed dose or accidentally double-dosing.

Compounded semaglutide conversion tables by vial concentration

Always check the vial label from your dispensing pharmacy to confirm whether your medication is mixed at 2.5 mg/mL, 5.0 mg/mL, or another custom strength.

Standard concentration: 2.5 mg/mL vial

This is the most common concentration dispensed by compounding pharmacies for starter and intermediate titration (Weeks 1 through 12):

Prescribed Dose (mg) Titration Phase Liquid Volume (mL) Syringe Markings (Units on U-100)
0.25 mg Starter (Weeks 1–4) 0.10 mL 10 Units
0.50 mg Escalation (Weeks 5–8) 0.20 mL 20 Units
0.75 mg Intermediate / Bridge 0.30 mL 30 Units
1.00 mg Therapeutic (Weeks 9–12) 0.40 mL 40 Units
1.70 mg Higher Therapeutic 0.68 mL 68 Units

High concentration: 5.0 mg/mL vial

Compounding pharmacies frequently switch patients to a 5.0 mg/mL concentration once they reach higher doses (1.0 mg and above) to avoid having to inject large liquid volumes:

Prescribed Dose (mg) Titration Phase Liquid Volume (mL) Syringe Markings (Units on U-100)
0.50 mg Escalation Dose 0.10 mL 10 Units
1.00 mg Therapeutic Dose 0.20 mL 20 Units
1.70 mg High Maintenance 0.34 mL 34 Units
2.00 mg High Maintenance 0.40 mL 40 Units
2.40 mg Maximum Maintenance 0.48 mL 48 Units

[!CAUTION] Double-Check Your Vial Before Titrating: If your pharmacy switches you from a 2.5 mg/mL vial to a 5.0 mg/mL vial, your unit volume is cut in half for the same dose of medicine. For example, 1.0 mg is 40 units in a 2.5 mg/mL vial, but only 20 units in a 5.0 mg/mL vial. Drawing 40 units from a 5.0 mg/mL vial would deliver 2.0 mg—a severe accidental overdose that can cause acute nausea, persistent vomiting, and dehydration.

The standard 5-step semaglutide titration schedule

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist with a half-life of approximately one week. Steady-state blood levels require 4 to 5 weeks to stabilize. Gradual dose escalation allows the gastrointestinal system to adapt to slowed gastric emptying.

The clinical titration protocol established in FDA trials follows a 16-to-20-week ramp:

[Weeks 1–4]  ──>  [Weeks 5–8]  ──>  [Weeks 9–12]  ──>  [Weeks 13–16]  ──>  [Week 17+]
  0.25 mg           0.50 mg            1.00 mg             1.70 mg           2.40 mg
(Initiation)       (Escalation)      (Therapeutic)       (High Dose)      (Max Maintenance)
Titration Step Weekly Dose Recommended Duration Primary Clinical Objective
Step 1: Starter Dose 0.25 mg / week Minimum 4 Weeks Acclimate digestive tract; evaluate GI tolerance; minimal appetite suppression expected.
Step 2: Escalation Dose 0.50 mg / week Minimum 4 Weeks Early satiety begins; portion sizes naturally decrease; modest initial weight loss.
Step 3: Therapeutic Dose 1.00 mg / week Minimum 4 Weeks Significant appetite regulation; metabolic improvements in fasting glucose and HbA1c.
Step 4: High-Dose Step 1.70 mg / week Minimum 4 Weeks Intensified satiety for patients plateauing at 1.0 mg; sustained metabolic control.
Step 5: Maximum Dose 2.40 mg / week Ongoing Maintenance Full FDA-approved clinical maintenance dose for long-term weight management.

Symptom-guided titration vs. calendar-forced escalation

One of the greatest advantages of telehealth physician management with compounded semaglutide is personalized dosing agility.

While drug manufacturers designed rigid 4-week calendar escalations for prefilled pens, clinical obesity specialists emphasize that titration should be symptom-guided:

  1. If you are actively losing 1 to 2 pounds per week and experiencing satisfying fullness at 0.50 mg or 1.00 mg without significant side effects, there is no medical requirement to escalate to higher doses.
  2. Remaining at the lowest effective dose minimizes medication costs, reduces the risk of gastrointestinal side effects, and leaves higher dose steps available if weight loss plateaus later in treatment.
  3. If nausea or reflux occurs after escalating, consult your provider about dropping back to your previous comfortable dose for an extra 2 to 4 weeks before attempting titration again.

Financial protection: avoiding dose-escalation price traps

Before choosing a telehealth clinic, pay close attention to how the provider prices higher doses. Many online clinics practice “teaser pricing”—offering low intro rates for starter doses while hiding steep surcharges on maintenance doses.

The tiered clinic trap vs. flat-rate pricing

  • Tiered Telehealth Clinics: These providers charge $179 to $199/month for starter doses (0.25mg and 0.50mg), but escalate monthly rates to $299/mo at 1.0mg and $349 to $399+/mo at 1.7mg and 2.4mg. Over a year, this tiered pricing increases your total treatment expense by $800 to $1,500+.
  • Flat-Rate Telehealth Providers: Transparent platforms maintain the same flat price regardless of dosage.
    • Wellmedr: Charges an introductory promo rate of $49 for month one, then a predictable flat $199 to $229 per month across all maintenance doses up to 2.4mg, saving patients hundreds of dollars as they titrate.
    • Gala Health: Packages multi-month bundles at an effective $179 to $199 per month with zero separate membership fees or dose surcharges.
Provider Model Starter Dose (0.25mg) Intermediate Dose (1.0mg) Max Dose (2.4mg) 6-Month Total Outlay
Tiered Telehealth Clinic $199 / mo $299 / mo $399 / mo ~$1,794
Gala Health (Prepaid Bundles) $199 / mo equiv. $199 / mo equiv. $199 / mo equiv. $1,194 (Save ~$600)
Wellmedr (Flat-Rate Monthly) $49 promo $229 / mo flat $229 / mo flat $1,194 (Save ~$600)

Conclusion: Choosing flat-rate providers like Wellmedr or Gala Health protects your budget from escalating medication bills as your treatment advances.

Safe administration, storage, and injection protocols

Proper storage and injection hygiene ensure medication potency and prevent injection-site irritation or bacterial contamination:

Storage and temperature requirements

  • Refrigerate Promptly: Compounded semaglutide must be stored in the refrigerator between 36°F and 46°F (2°C to 8°C). Never place the vial in the freezer or near the freezer cooling vent, as freezing destroys the delicate peptide protein structure.
  • Protect from Light: Store the vial inside its original pharmacy box or opaque pouch to shield the liquid from light degradation.
  • Beyond-Use Dating (BUD): In accordance with USP <797> sterile compounding standards, multi-dose vials with antimicrobial preservatives typically have a Beyond-Use Date of 28 days after the rubber stopper is first punctured. Do not use vials past their stated expiration or BUD date.

Subcutaneous injection steps

Compounded semaglutide is injected subcutaneously (into the fatty tissue directly beneath the skin), once every 7 days, with or without food:

  1. Wash Hands: Thoroughly clean hands with warm water and soap.
  2. Clean the Vial Stopper: Wipe the rubber top of the vial with a fresh 70% isopropyl alcohol swab and allow it to air-dry for 10 seconds.
  3. Draw the Dose: Remove the syringe needle cap. Pull the plunger back to draw air equal to your prescribed unit dose, insert the needle through the center of the rubber stopper, inject the air into the vial, invert the vial, and draw the exact unit volume. Tap the syringe gently to dislodge air bubbles.
  4. Select and Clean Injection Site: Choose an injection site on your abdomen (at least 2 inches away from the navel), the front of your thighs, or the back of your upper arm. Rotate your injection site every week to prevent localized lipodystrophy.
  5. Inject: Pinch a fold of skin, insert the needle at a 45-degree to 90-degree angle, smoothly depress the plunger completely, wait 5 seconds, and withdraw the needle. Dispose of the syringe immediately in an FDA-cleared sharps container.

Missed dose protocol

If you forget to take your weekly dose:

  • Within 5 Days: Take the missed dose as soon as you remember, then continue with your regular weekly injection schedule.
  • More Than 5 Days: Skip the missed dose entirely and resume on your next regularly scheduled injection day. Never inject a double dose to make up for a missed injection.

For full clinical instructions, spacing buffers, and what to do if you miss 2 or more consecutive weeks (14+ days), consult our comprehensive GLP-1 missed dose and titration resumption guide.